Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation - Target dose adjustment of busulfan in pediatric patients undergoing hematopoietic stem cell transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015166

Enrollment

Registered

2014-09-15

Start date

2013-05-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematological malignat disease, solid tumor, benign disease

Interventions

measurment of BU TDM

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patient who is planed stem cell transplantation with BU as pre-conditioning

Exclusion criteria

Exclusion criteria: 1 uncontroled infection 2 uncontroled mental disease 3 pregnantor possible pregnant womanan

Design outcomes

Primary

Measure	Time frame
1 year survival after transplantation	—

Countries

Japan

Contacts

Public ContactYoshiyuki Takahashi

Nagoya University Graduate School of Medicine Department of Pediatrics

ytakaha@med.nagoya-u.ac.jp052-744-2294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026